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Background
Elderly patients make up a large part of the breast can-
cer population and there are important specific consid-
erations for this population. Studies of elderly women
have found that Breast conservation therapy (ie, lum-
pectomy, axillary lymph node sampling, and postopera-
tive RT) is often associated with better quality of life.
Our Purpose was to evaluate the performance and feasi-
bility of sentinel lymph node biopsy in patients aged
≥ 65 in Day surgery (DS).
Materials and methods
Between January 2005 and July 2009, we performed 53
Sentinel Node Biopsy (SNB), in patients with median
age of 66 years, (range 24-87) with tumors of less than 3
cm with clinically negative axilla.
The sentinel node was successfully identified in all the
cases (100%) using technetium-99m (
99mTc) sulphur col-
loid, injected the day before surgery. The following day
the surgeon identified the sentinel node by gamma
probe and marked it on the skin. We never used vital
blue dye. In the great majority of patients we performed
SNB and quadrantectomy in day surgery (DS) and local
anaesthesia (LA) using the same incision or through a
separate small incision in the axilla (2-3 cm). This
approach was discussed with all patients and informed
consent was obtained. The whole procedure took a
median time of 40 minutes and all the patients tolerated
the procedure very well with minimum discomfort.
Results
We identified the SLN in all patients (100%).The most
common histological group was ductal carcinoma. Com-
plete standard axillary dissection followed only if the
sentinel node contained metastases. In 6 out of the
18 cases (32%) with istologically node-positive breast
cancer, the sentinel node was the only lymph node
affected. 2 cases showed a double SLN in the axilla. In
the group with a metastatic node 5 (27%) were aged ≥65
years. No axillary recurrences were observed. Our
results indicate that no significant disparities exist in the
sampling of axillary lymph nodes among women based
solely on their age.
Conclusion
This procedure is safe and well accepted in women aged
65 years and older. As regards hospital logistics, opera-
tions in DS and LA can be easily managed, leading to a
significant cost reduction.
No significant disparities exist in the sampling of axil-
lary lymph nodes among elderly women compared with
younger women, and the whole procedure can be done
in Day Surgery. The sentinel node biopsy remains a key
component in determining stage, and thereby prognosis
and appropriate treatment options also in elderly
women.
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